FA
CHE icon

Faithward Advisors’s Chemed CHE Stock Holding History

Faithward Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-351
Closed -$216K – 268
2025
Q1 		$216K Buy
+351
New +$200K 0.04% 245
2020
Q2 		– Sell
-1,542
Closed -$668K – 217
2020
Q1 		$668K Buy
1,542
+918
+147% +$410K 0.19% 76
2019
Q4 		$274K Buy
+624
New +$263K 0.06% 141

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Faithward Advisors's CHE Position: Q2 2025 in Review

Faithward Advisors sold out of Chemed (CHE) in Q2 2025, closing a stake of 351 shares — an estimated $216K sold.

Faithward Advisors first reported a position in CHE in Q4 2019 and held it in 3 quarters. The position peaked at $668K in Q1 2020. 537 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

  • Faithward Advisors reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
  • Faithward Advisors sold 351 Chemed shares in Q2 2025, an estimated $216K.
  • Faithward Advisors first reported a position in Chemed in Q4 2019 and held it in 3 quarters.
  • Faithward Advisors's Chemed position peaked at $668K in Q1 2020.
  • 537 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Faithward Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.